1. Home
  2. HD vs AMGN Comparison

HD vs AMGN Comparison

Compare HD & AMGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Home Depot Inc. (The)

HD

Home Depot Inc. (The)

HOLD

Current Price

$308.95

Market Cap

298.6B

ML Signal

HOLD

Logo Amgen Inc.

AMGN

Amgen Inc.

HOLD

Current Price

$352.16

Market Cap

183.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HD
AMGN
Founded
1978
1980
Country
United States
United States
Employees
N/A
N/A
Industry
RETAIL: Building Materials
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
298.6B
183.1B
IPO Year
1999
2002

Fundamental Metrics

Financial Performance
Metric
HD
AMGN
Price
$308.95
$352.16
Analyst Decision
Buy
Hold
Analyst Count
23
19
Target Price
$423.00
$351.05
AVG Volume (30 Days)
4.6M
2.0M
Earning Date
05-19-2026
04-30-2026
Dividend Yield
2.89%
2.98%
EPS Growth
N/A
88.23
EPS
3.30
3.34
Revenue
$66,176,000,000.00
$25,424,000,000.00
Revenue This Year
$7.13
$5.00
Revenue Next Year
$4.09
$2.45
P/E Ratio
$94.03
$103.42
Revenue Growth
N/A
8.83
52 Week Low
$289.10
$269.77
52 Week High
$426.75
$391.29

Technical Indicators

Market Signals
Indicator
HD
AMGN
Relative Strength Index (RSI) 43.47 63.64
Support Level $289.10 $334.95
Resistance Level $322.10 $356.53
Average True Range (ATR) 7.86 7.19
MACD 0.90 2.34
Stochastic Oscillator 61.58 90.33

Price Performance

Historical Comparison
HD
AMGN

About HD Home Depot Inc. (The)

Home Depot is the world's largest home improvement specialty retailer, operating 2,359 warehouse-format stores offering more than 30,000 products in store and 1 million products online in the US, Canada, and Mexico. Its stores offer building materials, home improvement products, lawn and garden products, and decor products and provide various services, including home improvement installation services and tool and equipment rentals. The acquisition of Interline Brands in 2015 allowed Home Depot to enter the MRO business, which has been expanded through the tie-up with HD Supply (2020). The 2024 tie-up with SRS will help grow professional demand in roofing, pool, and landscaping projects, while the 2025 purchase of GMS will lift building product sales through 1,250 distribution locations.

About AMGN Amgen Inc.

Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drugs Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx Pharmaceuticals bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brought several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.

Share on Social Networks: